Business & FinanceCanadaCanadian NewscannabisNewsPolitics And Policypsychedelic

Psychedelic drug companies prepare to enter Toronto stock market

You have 10 free articles left today, enjoy reading.

Companies are starting to develop medical treatments from psychedelic drugs such as LSD, ketamine and magic mushrooms. Mind Medicine Inc. is running clinical trials with psychedelic based drugs, according to Bloomberg.

“Our ambition is to be one of the first publicly listed neuro-pharmaceutical companies developing psychedelic medicines,” said JR Rahn, the company’s co-founder and co-chief executive. The company is currently gearing up to list on Canadian stock exchanges, pending final approvals. Mind Medicine Inc. is hoping to list on Toronto’s NEO Exchange by the first week of March.

While it may seem like a bit of a stretch for people to accept the idea of a company working with psychedelic drugs like MDMA and psilocybin, many Canadians quickly became comfortable with the legal use of cannabis since October 2018.

Companies have been experimenting at a growing rate with clinical trials of psychedelic treatments for mental health issues such as depression, post-traumatic stress disorder and curing addiction to other drugs such as nicotine and heroin.

The US Food and Drug Administration recently granted certain companies a legal way to conduct research on otherwise illegal drugs which will open the door to public listings.

Ronan Levy is the executive chairman of Field Trip Psychedelics Inc. and his company is building a network of clinics that will focus on ketamine-enhanced psychotherapy. The first clinic will open in Toronto as early as next month with more clinics to open in New York City in Los Angeles.

The work that these psychedelic companies are doing is legal in the U.S. because they aren’t using cannabis and that allows for “greater opportunity to access growth capital from private investors in the U.S. who may not touch cannabis,” Levy said.

It’s worth noting that this will be an industry separate from cannabis, which can only grow so large due to the substance’s illegality in the US The cannabis industry has also recently seen stock prices collapse amid slower sales in Canada as of late.

“I think that the psychedelics industry could be much bigger than the cannabis industry because it’s going to attract institutional capital and already is starting to,” Rahn said. “It’s also going to be a more concentrated space because the barriers to entry are much higher.”

Source link

The Post Millennial

Founded in 2017, The Post Millennial has become one of Canada’s fastest growing news organizations and one of the largest conservative news outlets in the world. It is owned and operated by the Après le Millénaire / The Post Millennial Corporation, located at 5369 Queen Marie, Montreal, H3X 1V1. At The Post Millennial, we strive to deliver the news to you as it unfolds, ensuring that you never fall behind on the current or trending news. With a particular verve for equality in thought, The Post Millennial provides various reports on today’s issues such as Canadian politics, business, local provincial news, analysis coverage and opinion pieces. To best deliver the news to you, The Post Millennial employs a dedicated team of journalists, podcast hosts, and video creators.
Back to top button
Hide picture